Obesity is a major health problem that predisposes individuals to diabetes, cardiovascular disease and cancer. Excessive caloric intake is linked to resistance of hypothalamic homeostatic centers to peripheral feedback signals and to hedonic processes involving limbic circuits that mediate the reinforcing value of palatable food. These neural pathways interact with each other, but the mechanisms are largely unknown. Our work has focused on hypothalamic proopiomelanocortin (POMC) neurons that, together with adjacent AGRP/NPY neurons, integrate interoceptive signals of nutritional state and regulate food intake and energy expenditure. We have developed a unique mouse model of hypothalamus-specific POMC-deficiency with the capacity for POMC re-expression. These mice exhibit genetically reversible hyperphagia, obesity, meal pattern alterations and decreased locomotor activity, and were used to test the functional importance of POMC neuron heterogeneity and the absolute number of POMC neurons required to regulate energy balance. We discovered that POMC neurons synaptically release GABA and glutamate and, by using a genetic strategy to fluorescently tag synaptophysin in POMC neurons, we identified discrete synaptophysin-positive boutons that were immuno- labeled either for POMC peptides, GABA, or glutamate. POMC neurons were shown to project to multiple brain areas that integrate energy status with motivational, rewarding and locomotor behaviors. Therefore, our goal for the next competing cycle of this project is to test the hypothesis that hypothalamic POMC neurons are in synaptic contact with limbic circuit neurons, physiologically modulate their activity through the differentil release of melanocortin peptides, ?-endorphin and amino acid neurotransmitters, and influence appetitive behaviors and locomotor activity related to food acquisition and consumption. We will experimentally address this overarching hypothesis through the following three specific aims. 1) Map the location and neurochemical properties of afferent and efferent neurons with monosynaptic connections to arcuate POMC neurons, focusing on the nucleus accumbens, bed nucleus of the stria terminalis, paraventricular nucleus of the thalamus, and the ventral tegmental area. 2) Directly measure basal levels and stimulated release of the neuropeptides and amino acid neurotransmitters produced by POMC neurons in the nuclei named above that comprise the limbic motivational circuit. These experiments will employ brain microdialysis directly coupled on-line to a novel capillary liquid chromatography/mass spectrometry system capable of simultaneously detecting multiple neuropeptides with picomolar sensitivity. 3) Test the hypothesis that POMC neuron/melanocortin projections to the mesocorticolimbic dopamine pathway modulate locomotor activity and appetitive motivation for food. Together, these investigations of hypothalamic POMC neurons will provide new mechanistic insights regarding the complex links between the homeostatic and hedonic control of feeding, dysregulation of which may underlie the obesity epidemic in the modern world.

Public Health Relevance

Obesity predisposes humans to type 2 diabetes, cardiovascular disease and several cancers. The number of obese and overweight people, and particularly those with diabetes, is increasing world-wide with major health and economic consequences. A full understanding of how the brain controls energy balance and how that control is broken in the context of obesity remains elusive. This project will continue to explore the role of a subset of neurons that are critically involved in the regulation of appetite, satiatin, feeding, metabolism, activity and blood sugar.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK066604-11
Application #
9187838
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Hyde, James F
Project Start
2003-12-15
Project End
2019-11-30
Budget Start
2016-12-01
Budget End
2017-11-30
Support Year
11
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Physiology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Steyn, Frederik J; Ngo, Shyuan T; Chen, Vicky Ping et al. (2018) 17?-estradiol acts through hypothalamic pro-opiomelanocortin expressing neurons to reduce feeding behavior. Aging Cell 17:
Zestos, Alexander G; Carpenter, Colleen; Kim, Youngsoo et al. (2018) Ruboxistaurin Reduces Cocaine-Stimulated Increases in Extracellular Dopamine by Modifying Dopamine-Autoreceptor Activity. ACS Chem Neurosci :
Zhou, Yan; Rubinstein, Marcelo; Low, Malcolm J et al. (2018) V1b Receptor Antagonist SSR149415 and Naltrexone Synergistically Decrease Excessive Alcohol Drinking in Male and Female Mice. Alcohol Clin Exp Res 42:195-205
Kim, Geun Hyang; Shi, Guojun; Somlo, Diane Rm et al. (2018) Hypothalamic ER-associated degradation regulates POMC maturation, feeding, and age-associated obesity. J Clin Invest 128:1125-1140
Chhabra, Kavaljit H; Morgan, Donald A; Tooke, Benjamin P et al. (2017) Reduced renal sympathetic nerve activity contributes to elevated glycosuria and improved glucose tolerance in hypothalamus-specific Pomc knockout mice. Mol Metab 6:1274-1285
Burke, Luke K; Ogunnowo-Bada, Emmanuel; Georgescu, Teodora et al. (2017) Lorcaserin improves glycemic control via a melanocortin neurocircuit. Mol Metab 6:1092-1102
Rubinstein, Marcelo; Low, Malcolm J (2017) Molecular and functional genetics of the proopiomelanocortin gene, food intake regulation and obesity. FEBS Lett 591:2593-2606
Sundaresan, Sinju; Meininger, Cameron A; Kang, Anthony J et al. (2017) Gastrin Induces Nuclear Export and Proteasome Degradation of Menin in Enteric Glial Cells. Gastroenterology 153:1555-1567.e15
Zhou, Y; Rubinstein, M; Low, M J et al. (2017) Hypothalamic-specific proopiomelanocortin deficiency reduces alcohol drinking in male and female mice. Genes Brain Behav 16:449-461
Low, Malcolm J (2016) Neuroendocrinology: New hormone treatment for obesity caused by POMC-deficiency. Nat Rev Endocrinol 12:627-628

Showing the most recent 10 out of 41 publications